
Clinical Chemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Description
Clinical Chemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Summary
GlobalData's Medical Devices sector report, “Clinical Chemistry Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Clinical Chemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Clinical chemistry rapid tests provide the test results immediately. These tests are used in low resource settings with the help of test strips, tablets and solutions. Clinical chemistry PoC diagnostics are used to determine the concentration or activity of blood gas, electrolytes, metabolites, enzymes, carbohydrates, proteins, lipids and small molecules.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
The report enables you to -
Summary
GlobalData's Medical Devices sector report, “Clinical Chemistry Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Clinical Chemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Clinical chemistry rapid tests provide the test results immediately. These tests are used in low resource settings with the help of test strips, tablets and solutions. Clinical chemistry PoC diagnostics are used to determine the concentration or activity of blood gas, electrolytes, metabolites, enzymes, carbohydrates, proteins, lipids and small molecules.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Clinical Chemistry Rapid Tests & POC under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Clinical Chemistry Rapid Tests & POC and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Clinical Chemistry Rapid Tests & POC under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
223 Pages
- About GlobalData
- Clinical Chemistry Rapid Tests & POC Overview
- Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development
- Clinical Chemistry Rapid Tests & POC - Pipeline Products by Territory
- Clinical Chemistry Rapid Tests & POC - Pipeline Products by Regulatory Path
- Clinical Chemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date
- Clinical Chemistry Rapid Tests & POC - Ongoing Clinical Trials
- Clinical Chemistry Rapid Tests & POC Companies - Pipeline Products by Stage of Development
- Clinical Chemistry Rapid Tests & Companies POC - Companies Pipeline Products by Stage of Development
- Abreos Biosciences Inc Company Overview
- Acetaminophen Toxicity Diagnostics, LLC Company Overview
- Affinergy LLC Company Overview
- Am Biotechnologies, LLC Company Overview
- AnaZyme LLC Company Overview
- Angle Biosciences Inc Company Overview
- Augurix SA Company Overview
- Baebies Inc Company Overview
- Base Pair Biotechnologies Inc Company Overview
- Biocross SL Company Overview
- Bioftalmik Applied Research Company Overview
- Biotech Resources Aust Pty Ltd Company Overview
- Boditech Med Inc Company Overview
- Burnet Institute Company Overview
- Calmark Sweden AB Company Overview
- Cambridge Diagnostic Imaging Ltd Company Overview
- Carclo Diagnostic Solutions Ltd Company Overview
- CardioGenics Inc Company Overview
- Cellex Inc Company Overview
- Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview
- Claremont BioSolutions Company Overview
- Columbia University Company Overview
- DiaSys Diagnostic Systems GmbH Company Overview
- Edan Instruments Inc Company Overview
- Foundation for Innovative New Diagnostics Company Overview
- GlucoSentient Inc Company Overview
- Group K Diagnostics Company Overview
- Instrumentation Laboratory Co Company Overview
- IPI Singapore Company Overview
- IR2Dx Inc. Company Overview
- Magee-Womens Research Institute Company Overview
- Massachusetts Institute of Technology Company Overview
- Medical University of South Carolina Company Overview
- MiCo BioMed Co Ltd Company Overview
- Monash University Company Overview
- Montana State University Company Overview
- NanoSpeed Diagnostics Inc Company Overview
- Ohmx Corp Company Overview
- OPKO Health Inc Company Overview
- Oxford Immunotec Ltd Company Overview
- Pennsylvania State University Company Overview
- PortaScience Inc Company Overview
- ProciseDx LLC Company Overview
- Quidel Corp Company Overview
- SaltCheck Inc (Inactive) Company Overview
- Seattle Children's Hospital Company Overview
- SenGenix Inc Company Overview
- Systagenix Wound Management Ltd Company Overview
- The University of New South Wales press Limited Company Overview
- Thermo Fisher Scientific Inc Company Overview
- Universal Biosensors Inc Company Overview
- University of Edinburgh Company Overview
- University of Florida Company Overview
- University of South Australia Company Overview
- UrSure Inc Company Overview
- Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
- Aug 11, 2022: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update
- Aug 11, 2022: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022
- Aug 10, 2022: Volitionrx Announces Second Quarter 2022 Financial Results and Business Update
- Aug 10, 2022: Biohit announce Half Year Financial Report 2022.
- Aug 09, 2022: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update
- Aug 08, 2022: Volition appoints DXOCRO to spearhead U.S. FDA strategy
- Aug 04, 2022: Celcuity Schedules Release of Second Quarter 2022 Financial Results and Webcast/Conference Call
- Aug 01, 2022: Smiths Group Announce Directorate Change
- Jul 28, 2022: Samsung Electronics Announces Second Quarter 2022 Results
- Jul 28, 2022: Balfour Beatty teams up with Steps to Hope to raise funds for people in need
- Jul 28, 2022: Bio-rad Reports Second-quarter 2022 Financial Results
- Jul 28, 2022: Grifols Report EUR 2,810.1 million revenues in first half of 2022
- Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
- Jul 24, 2022: Central Trust Buys 136 Shares of Novartis AG
- Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
- Jul 18, 2022: Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
- Jul 14, 2022: MedMira Strengthens and Expands Board
- Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
- Jul 01, 2022: Novartis Leaning Toward Spinoff of $25 Billion Generics Arm
- Jun 28, 2022: Novartis to cut up to 8,000 jobs globally
- Jun 21, 2022: Lumos Diagnostics Appoints Doug Ward As CEO
- Jun 09, 2022: Samsung Electronics Vice Chairman Lee Flies into Germany
- Jun 09, 2022: EKF Diagnostics Holdings : Launch of EKF Link
- Jun 07, 2022: BD Names Simon Campion as Medical Segment President
- Jun 02, 2022: BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
- Jun 01, 2022: Agilent releases IVDR-compliant instruments, kits, and reagents for use in the European Union
- May 19, 2022: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update
- May 16, 2022: Celcuity Reports First Quarter 2022 Financial Results and Business Updates
- May 11, 2022: Babson, BD expand strategic partnership to advance diagnostic blood collection in new care settings
- May 11, 2022: VolitionRx Announces First Quarter 2022 Financial Results and Business Update
- May 10, 2022: Qualigen Therapeutics' Partner NanoSynex to Present Technology at BioMed Israel
- May 09, 2022: Samsung hires Marco Chisari as executive vice president of SSIC and foundry business in US
- Apr 29, 2022: BD to Present at the BofA Securities 2022 Healthcare Conference
- Apr 28, 2022: Illumina to Webcast Upcoming Investor Conference
- Apr 25, 2022: Samsung appoints New Co-CEO for smartphone and chip manufacturing
- Apr 25, 2022: EKF Diagnostics Holdings announces Posting of Annual Report & Accounts &Notice of AGM
- Apr 19, 2022: Tn Antigen: Peter Mac interim development clinical study results
- Apr 11, 2022: Thermo Fisher Scientific to Host Investor Day
- Apr 11, 2022: John Frank Joins Illumina as Chief Public Affairs Officer
- Apr 07, 2022: Quidel Announces Preliminary Revenue for First Quarter 2022
- Apr 06, 2022: Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process
- Apr 04, 2022: Novartis appoints Shreeram Aradhye as chief medical officer
- Apr 01, 2022: NTU Singapore researchers develop an efficient and precise motion capture system to aid in physiotherapy and athletics
- Mar 30, 2022: VolitionRx Announces Full Fiscal Year 2021 Financial Results and Business Update
- Mar 29, 2022: Genedrive Announces Interim results to 31 December 2021
- Mar 28, 2022: ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update
- Mar 25, 2022: Smiths Group Announce half year results for 6 months ended 31 January 2022
- Mar 25, 2022: Smiths Group plc Half Year Results 2022
- Mar 17, 2022: Genedrive Appoints Russell John Shaw as Chief Financial Officer
- Mar 04, 2022: Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
- Mar 03, 2022: binx health Announces Appointment of UnitedHealth Group's Optum Rx Chief Financial Officer Jeff Grosklags to its Board of Directors
- Mar 02, 2022: Smiths Group Director Change
- Feb 24, 2022: BD to Present at the Cowen 42nd Annual Health Care Conference
- Feb 23, 2022: embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD
- Feb 23, 2022: Bd Appoints Shana Neal as Chief People Officer
- Feb 22, 2022: Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
- Feb 15, 2022: Samsung Electronics Announce Appointment of New Chief Executive Officer
- Feb 14, 2022: Bio-Rad Laboratories to Post Q1 2022 Earnings of $2.80 Per Share, Jefferies Financial Group Forecasts
- Feb 11, 2022: Span Divergent Un-Audited Financial Results for the Quarter Ended 31st December 2021
- Feb 02, 2022: Novartis Announces 2021 Financial Results
- Feb 02, 2022: Bio-Rad to Host Investor Day on February 25
- Jan 31, 2022: EKF Diagnostics Holdings Announces Non-executive Directorate Change
- Jan 31, 2022: MedMira Reports Second Quarter Results FY2022
- Jan 27, 2022: Samsung Electronics Announces Fourth Quarter and FY 2021 Results
- Jan 19, 2022: Omega Diagnostics Group Announces Directorate Change
- Jan 07, 2022: Samsung Electronics Announces Earnings Guidance for Fourth Quarter 2021 January 7, 2022
- Jan 07, 2022: Samsung Electronics Announces Earnings Guidance for Fourth Quarter 2021
- Jan 07, 2022: Quidel Announces Preliminary Revenue for Fourth Quarter 2021
- Jan 06, 2022: BD Announces Change to Virtual 2022 Annual Meeting of Shareholders
- Jan 05, 2022: BD to announce financial results for its first quarter of fiscal year 2022
- Dec 23, 2021: Illumina To Webcast Upcoming Investor Conference
- Dec 21, 2021: BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business
- Dec 17, 2021: MedMira appoints Thomas Bergmann to board
- Dec 15, 2021: Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company's Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
- Dec 09, 2021: Samsung Electronics promotes young leaders as board member
- Dec 07, 2021: Samsung Electronics Announces New Leadership
- Nov 30, 2021: MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
- Nov 25, 2021: Omega Diagnostics Group Announces Interim Results for the Six Months Ended 30 September 2021
- Nov 23, 2021: EKF Diagnostics Holdings Appoints Marc Davies as Chief Financial Officer
- Nov 17, 2021: Genedrive notice of AGM
- Nov 16, 2021: Genedrive Announces Directorate Change
- Nov 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2021, and Provides Corporate Update
- Nov 11, 2021: General Industry Smiths Group Q1 Trading Statement FY2022Smiths Group Q1 Trading Statement FY2022 11 November 2021 Q1 Trading Statement FY2022
- Nov 10, 2021: VolitionRx Announces Third Quarter 2021 Financial Results and Business Update
- Nov 09, 2021: Genedrive announces Final Results
- Nov 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update
- Nov 04, 2021: Quidel Reports Third Quarter 2021 Financial Results
- Oct 30, 2021: MedMira Reports First Quarter Results FY2022
- Oct 28, 2021: Samsung Electronics reports Q3 2021 results
- Oct 26, 2021: Novartis Financial Results Q3 2021
- Oct 26, 2021: SRI International Names Dr. David E. Parekh as CEO
- Oct 26, 2021: BD to Host Investor Day on November 12
- Oct 21, 2021: Columbia Provides Update on University's Fiscal 2021 Results
- Oct 19, 2021: Smiths Group announces Annual Financial Report
- Oct 07, 2021: Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021
- Sep 23, 2021: Dr. Mikael Dolsten Named to Agilent Board of Directors
- Sep 22, 2021: Sandia Labs breaks ground on state-of-the-art Emergency Operations Center
- Sep 14, 2021: EKF Diagnostics Holdings Announces unaudited interim results for the six months ended 30 June 2021
- Sep 07, 2021: binx health adds Industry Leaders, Elizabeth Mora and Naomi Kelman to Board of Directors
- Sep 01, 2021: BioMerieux announce First-Half 2021 Results
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.